MD FRCP FRCOphth FHEA DCH DRCOG DO
- Tutor and Senior Research Fellow, Harris Manchester College
Prof. Peter Scanlon has been Clinical Director for the English NHS Diabetic Eye Screening Programme since 2003, and he has, with the support and co-operation of colleagues, moved screening from limited ad hoc delivery of services to systematic quality assured processes for screening, assessment and treatment across all of England to 2.3 million people with diabetes. Dr Scanlon also holds an appointment as a Senior Research Fellow and Medical Tutor at Harris Manchester College, University of Oxford, and as Visiting Professor at the University of Gloucestershire. Dr Scanlon is Lead Author of the textbook ‘Practical Manual of Diabetic Retinopathy Management’ and has written the Diabetic Retinopathy Chapter for the Textbook of Diabetes, 4th Edition (both Wiley Blackwell).
His research interests lie in the Screening, Epidemiology, Assessment and Treatment of Diabetic Retinopathy and he has published extensively in these areas.
Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort.
Smith JJ. et al, (2021), Br J Ophthalmol
Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy
Lois N. et al, (2021), Ophthalmology, 128, 561 - 573
The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.
Scanlon PH., (2021), Acta Diabetol, 58, 521 - 530
Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West England.
Nevill CR. et al, (2021), Eye (Lond)
International Students Undertaking UK University-Validated Distance-Learning Courses in Diabetic Retinopathy Screening (DRS)
Aldington S. et al, (2020), EUROPEAN JOURNAL OF OPHTHALMOLOGY, 30, 14 - 14